Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-036554
Filing Date
2014-05-23
Accepted
2014-05-23 13:50:27
Documents
1
Period of Report
2014-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4109
  Complete submission text file 0001209191-14-036554.txt   5530
Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MIRATI THERAPEUTICS, INC. 9363 TOWNE CENTRE DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address
Christensen Jamie (Reporting) CIK: 0001599324 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 14866616